Business Context and Reporting Period
This Form 6-K filing by Evaxion A/S covers the month of April 2026, specifically detailing the resolutions passed at the Annual General Meeting (AGM) held on April 16, 2026. The Company is a foreign private issuer headquartered in Hoersholm, Denmark. The filing incorporates the amended Articles of Association resulting from shareholder votes.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity for the current or prior periods. The document confirms that the audited annual report for the financial year 2025 was approved, and the loss for that year was transferred to the next financial year, but no numerical figures regarding the loss amount or balance sheet items are disclosed in this summary.
Material Changes and Corporate Actions
- Shareholder Participation: 104,894,401 ordinary shares, representing 25.15% of outstanding shares, were voted at the AGM.
- Board Composition: Marianne Søgaard, Lars Holtug, Lars Aage Staal Wegner, and Roberto Prego Pineda were re-elected. Jens Bitsch-Nørhave was elected as a new board member.
- Auditor: EY Godkendt Revisionspartnerselskab was re-elected as the Company's auditor.
- Capital Authorization (Warrants): Shareholders authorized the Board to issue warrants to directors, management, and key employees with a total nominal value of up to DKK 11,900,000. This authorization is valid until April 15, 2029.
- Capital Authorization (Convertible Notes): Shareholders authorized the Board to obtain loans against the issuance of convertible loan notes with a total nominal value of up to DKK 73,500,000. This authorization is valid until April 15, 2031.
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance, management commentary on future financial performance, or specific risk factors beyond the standard implications of capital dilution inherent in the new authorizations. The Board was granted authority to determine terms for warrants and convertible notes, with exercise/conversion prices required to be at market price (defined as +/-10% of the listed price on a relevant European or US exchange).
Investor Verification Checklist
- Verify the specific terms and vesting schedules for the new warrant program (DKK 11.9M nominal) once issued by the Board.
- Monitor the Company's capital structure for any issuance of convertible loan notes under the new DKK 73.5M authorization.
- Review the full audited annual report for 2025 to determine the exact magnitude of the loss transferred to the next financial year.
- Confirm the impact of the new board member, Jens Bitsch-Nørhave, on future strategic direction.